MSI Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History

MSI Financial Services’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$132K	Buy	4,580 +100	+2%	+$2.65K	﹤0.01%	1299
2016 Q3	$143K	Sell	4,480 -530	-11%	-$18K	﹤0.01%	1225
2016 Q2	$163K	Buy	5,010 +41	+0.8%	+$1.37K	0.01%	1129
2016 Q1	$139K	Sell	4,969 -461	-8%	-$10.1K	0.01%	1169
2015 Q4	$194K	Buy	5,430 +930	+21%	+$32.8K	0.01%	963
2015 Q3	$149K	Sell	4,500 -500	-10%	-$20.8K	0.01%	750
2015 Q2	$209K	Sell	5,000 -2,450	-33%	-$94.8K	0.01%	696
2015 Q1	$243K	Sell	7,450 -200	-3%	-$6.88K	0.02%	667
2014 Q4	$243K	Buy	7,650 +2,300	+43%	+$65.2K	0.03%	531
2014 Q3	$132K	Hold	5,350	–	–	0.02%	715
2014 Q2	$121K	Hold	5,350	–	–	0.02%	735
2014 Q1	$130K	Hold	5,350	–	–	0.02%	670
2013 Q4	$134K	Sell	5,350 -250	-4%	-$5.9K	0.02%	651
2013 Q3	$154K	Sell	5,600 -2,200	-28%	-$46K	0.03%	519
2013 Q2	$142K	Buy	+7,800	New	+$107K	0.03%	507

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

MSI Financial Services's ACAD Position: Q4 2016 in Review

MSI Financial Services increased its Acadia Pharmaceuticals (ACAD) stake by 2.2% in Q4 2016, buying an estimated $2.65K and bringing the position to 4,580 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

MSI Financial Services first reported a position in ACAD in Q2 2013 and has held it in 15 quarters since. The position peaked at $243K in Q1 2015. 225 funds tracked by Wall St. Rank hold ACAD as of Q4 2016.

MSI Financial Services held 4,580 shares of Acadia Pharmaceuticals worth $132K as of Q4 2016.
MSI Financial Services bought 100 Acadia Pharmaceuticals shares in Q4 2016, an estimated $2.65K.
Acadia Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #1299 holding.
MSI Financial Services first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
MSI Financial Services's Acadia Pharmaceuticals position peaked at $243K in Q1 2015.
225 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.